Pediatric Toxoplasmosis Workup

  • Author: Itzhak Brook, MD, MSc; Chief Editor: Russell W Steele, MD   more...
 
Updated: Sep 28, 2011
 

Approach Considerations

Demonstration of T gondii in blood, body fluids, or tissues is evidence of toxoplasmosis infection (see the image below). Isolation by mouse inoculation of Toxoplasma from amniotic fluid or placental or fetal tissue is diagnostic of congenital infection. Lymphocyte transformation in response to Toxoplasma antigens indicates previous infection in adults. Detection of Toxoplasma antigens in blood or body fluids by means of enzyme-linked immunoassay (ELISA) or polymerase chain reaction indicates acute infection. A skin test showing delayed hypersensitivity to Toxoplasma antigens may be a useful screening test.

Laboratory tests include complete blood cell (CBC) count with differential, liver function tests, lumbar puncture, serum creatinine, urinalysis, urine viral culture for cytomegalovirus, and serum quantitative immunoglobulin testing.

Toxoplasma gondii trophozoites in tissue culture. Toxoplasma gondii trophozoites in tissue culture.

The Sabin-Feldman dye test is a sensitive and specific neutralization test. It measures IgG antibody and is the standard reference test for toxoplasmosis; however, it requires live T gondii and thus is not available in most laboratories. High titers suggest acute disease.

The indirect fluorescent antibody (IFA) test measures the same antibodies as the dye test. Titers parallel dye test titers. The IgM fluorescent antibody test can be used to detect IgM antibodies within the first week of infection, but titers fall within a few months. The double-sandwich IgM ELISA test is more sensitive and specific than other IgM detection tests.

The indirect hemagglutination test measures a different antibody than does the dye test. Titers tend to be higher and remain elevated longer.

The IgG avidity test may be able to discriminate acute from chronic infection better than alternative assays, such as assays that measure IgM antibodies, can. As is true for IgM antibody tests, the avidity test is most useful when performed early in gestation, because a chronic pattern occurring late in pregnancy does not rule out the possibility that the acute infection may have occurred during the first months of gestation. A 2-fold rise in serum IgG obtained at 3-week intervals is diagnostic.

Perform an amniocentesis at 20-24 weeks' gestation in suspected cases of congenital disease. Performing polymerase chain reaction (PCR) assay testing on body fluids, including cerebrospinal fluid (CSF), amniotic fluid, bronchoalveolar lavage fluid, and blood, may be useful in establishing the diagnosis.[6]

Antibody levels in aqueous humor or CSF obtained through a lumbar puncture may reflect local antibody production and infection at these sites.

Next

Imaging Studies

Ultrasonography

Ultrasonography of the fetus to evaluate for evidence of congenital toxoplasmosis can be performed at 20-24 weeks' gestation.

CT scanning

Computed tomography (CT) scanning of the brain is useful in cerebral toxoplasmosis. In 70-80% of immunodeficient patients with Toxoplasma encephalitis, the CT scan reveals multiple bilateral, ring-enhancing cerebral lesions. Although multiple lesions are more common, finding a solitary lesion should not exclude Toxoplasma encephalitis. There is an approximately 80% likelihood that the disease is present in patients with AIDS who have detectable Toxoplasma IgG and multiple ring-enhancing lesions. Lesions are characteristically hypodense and tend to occur at the corticomedullary junction; they frequently involve the basal ganglia.

CT scanning frequently underestimates the number of lesions, although delayed imaging after a double dose of intravenous (IV) contrast material may improve the sensitivity of this imaging modality. An enlarging, hypodense lesion that does not enhance is a poor prognostic finding.

Improvement is seen in as many as 90% of patients with AIDS and Toxoplasma encephalitis after 2-3 weeks of treatment. Complete resolution lasts from 6 weeks to 6 months; peripheral lesions resolve more rapidly than do deeper ones. Radiographic response tends to lag behind clinical response.

MRI

Magnetic resonance imaging (MRI) is the preferred imaging modality to evaluate for lesions. MRI has superior sensitivity, particularly if gadolinium is used for contrast. It can often depict lesions or more extensive disease not apparent on CT scans. Hence, MRI should be used as the initial imaging procedure when feasible and should always follow CT demonstration of a single lesion.

MRI depicts Toxoplasma encephalitis lesions as high-signal abnormalities on T2-weighted studies and reveals a rim of enhancement surrounding the edema on T1-weighted, contrast-enhanced images.

Smaller lesions usually completely resolve on MRI studies within 3-5 weeks, but lesions with a mass effect tend to resolve more slowly and leave a small, residual lesion.

Even characteristic lesions on CT or MRI are not pathognomonic of Toxoplasma encephalitis. The major differential diagnosis in patients with AIDS is CNS lymphoma, which appears with multiple enhancing lesions in 40% of cases.

When single lesions are depicted on MRI, the probability of Toxoplasma encephalitis falls and that of lymphoma rises. Brain biopsy findings are generally required to obtain a definitive diagnosis.

Other modalities

To evaluate patients with AIDS and focal CNS lesions, various positron emission tomography (PET) and radionuclide scans have been used, generally with minimal benefit over the above modalities.

Previous
Next

Histologic Findings

The histopathology of toxoplasmosis varies with the immune status of the host. In the healthy host with acquired toxoplasmosis, the characteristic histopathology of the lymph node is diagnostic, despite the relative paucity of organisms present. Typical findings include reactive follicular hyperplasia, irregular clusters of histiocytes encroaching on the margins of germinal centers, and focal distention of sinuses with monocytoid cells. Necrosis, granuloma formation, microabscesses, and vasculitis do not occur. At autopsy of normal hosts, tissue cysts are noted as incidental findings in skeletal muscle and myocardium, invoking little inflammatory response.

In contrast, in patients who are immunodeficient and in children with severe congenital toxoplasmosis, tachyzoite proliferation is accompanied by tissue necrosis and an intense, usually monocytic, inflammatory response. In patients with AIDS, toxoplasmosis typically produces brain abscesses that have a characteristic appearance. A central avascular area is surrounded by a region of necrosis and inflammatory cells that may also contain free and intracellular tachyzoites. Outside of the region of inflammation are cysts.

Demonstration of tachyzoites in a tissue specimen is required for definitive diagnosis of active infection. The presence of multiple cysts near an inflammatory lesion makes the diagnosis highly likely. Stains used to detect tachyzoites or cysts include hematoxylin and eosin, periodic acid-Schiff, and Gomori-methenamine silver. Immunoperoxidase and fluorescein-conjugated antibody stains can also be used.

Previous
 
 
Contributor Information and Disclosures
Author

Itzhak Brook, MD, MSc  Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases, Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society

Disclosure: Nothing to disclose.

Coauthor(s)

Hakan Leblebicioglu, MD  Chairman, Professor, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University School of Medicine, Turkey

Hakan Leblebicioglu, MD is a member of the following medical societies: American Society for Microbiology and European Society of Clinical Microbiology and Infectious Diseases

Disclosure: Nothing to disclose.

Murat Hökelek, MD, PhD  Technical Consultant of Parasitology Laboratory, Professor, Department of Clinical Microbiology, Ondokuz Mayis University Medical School, Turkey

Murat Hökelek, MD, PhD is a member of the following medical societies: Turkish Society for Parasitology

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Leslie L Barton, MD  Professor Emerita of Pediatrics, University of Arizona College of Medicine

Leslie L Barton, MD is a member of the following medical societies: American Academy of Pediatrics, Association of Pediatric Program Directors, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. Jun 2005;6(1):41-61. [Medline].

  2. Ferguson W, Mayne PD, Lennon B, Butler K, Cafferkey M. Susceptibility of pregnant women to toxoplasma infection--potential benefits for newborn screening. Ir Med J. Jul-Aug 2008;101(7):220-1. [Medline].

  3. Trikha I, Wig N. Management of toxoplasmosis in AIDS. Indian J Med Sci. 2001;55:87-98. [Medline].

  4. Jones JL, Lopez A, Wilson M, et al. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001;56:296-305. [Medline].

  5. Berrebi A, Assouline C, Bessieres MH, et al. Long-term outcome of children with congenital toxoplasmosis. Am J Obstet Gynecol. Jul 14 2010;[Medline].

  6. Bonfioli AA, Orefice F. Toxoplasmosis. Semin Ophthalmol. Jul-Sep 2005;20(3):129-41. [Medline].

  7. Foulon W, Naessens A, Ho-Yen D. Prevention of congenital toxoplasmosis. J Perinat Med. 2000;28:337-45. [Medline].

Previous
Next
 
Toxoplasma gondii trophozoites in tissue culture.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.